Skip to main content Back to Top
Advertisement

12/5/2019

Melphalan Injection

Products Affected - Description

    • Melphalan powder for solution for injection, Fresenius Kabi, 50 mg, vial, 1 count, NDC 63323-0760-20
    • Melphalan powder for solution for injection, Par Pharmaceuticals, 50 mg, vial, 1 count, NDC 42023-0129-01

Reason for the Shortage

    • Mylan Institutional has melphalan injection available.
    • Par did not provide a reason for the shortage.
    • Sagent is not currently marketing melphalan injection.

Available Products

    • Evomela powder for solution for injection, Spectrum, 50 mg, vial, 1 count, NDC 68152-0109-00
    • Melphalan powder for solution for injection, Mylan Institutional, 50 mg, vial, 1 count, NDC 67457-0195-01
    • Melphalan powder for solution for injection, Teva, 50 mg, vial, 1 count, NDC 45963-0686-02

Estimated Resupply Dates

    • Fresenius Kabi has short-dated melphalan 50 mg vials available with an expiration date of <9 months.
    • Par has melphalan 50 mg vials on back order and the company cannot estimate a release date.

Updated

Updated December 5, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created January 28, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins